PANoptosis-mediated mechanisms underlying AST elevation in Talaromyces marneffei infection

Wudi Wei1, Baili Zhan1, Lixiang Chen2

  • 1Joint Laboratory for Emerging Infectious Diseases in China (Guangxi)-ASEAN, Life Sciences Institute, Guangxi Medical University, Guangxi. China.

PubMed
Abstract

Insights

Talaromyces marneffei infection elevates aspartate aminotransferase (AST) by triggering PANoptosis-mediated liver cell death and inflammation. AST may help diagnose and monitor Talaromycosis in HIV patients.

Area of Science:

  • Mycology
  • Immunology
  • Pathology

Background:

  • Talaromyces marneffei is an opportunistic fungal pathogen causing severe infections, particularly in Southeast Asia.
  • Elevated aspartate aminotransferase (AST) is common in T. marneffei infections, but its origin and significance are unclear.
  • Investigating AST's role could improve diagnosis and understanding of T. marneffei pathogenesis.

Purpose of the Study:

  • To determine if AST is a specific indicator of T. marneffei infection.
  • To elucidate the mechanisms behind AST elevation, tissue damage, and cell death in T. marneffei infection.

Main Methods:

  • Retrospective analysis of clinical data from HIV/AIDS patients with and without T. marneffei infection.
  • Establishment of a murine model to track AST distribution in tissues.
  • Assessment of PANoptosis markers and inflammatory cytokines using ELISA, qPCR, and Western blotting.

Main Results:

  • HIV/T. marneffei co-infected patients showed significantly higher AST than HIV-only patients; levels decreased with treatment.
  • In mice, AST increased in plasma and organs, with the liver showing the highest concentration and the spleen the greatest fold increase.
  • Liver tissues displayed upregulated PANoptosis markers and elevated pro-inflammatory cytokines (Tnf-α, Il-1β, Il-18), while the spleen showed suppressed inflammation.

Conclusions:

  • T. marneffei infection induces PANoptosis-mediated hepatocyte death and liver inflammation, leading to AST elevation.
  • AST shows potential as an auxiliary biomarker for early diagnosis and treatment monitoring of Talaromycosis.
  • Understanding the link between PANoptosis, inflammation, and AST is crucial for managing T. marneffei infections.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...